newsfilter
← Latest News
PR Newswire·

Ampio Pharmaceuticals Regains Compliance with NYSE American Continued Listing Standards

ENGLEWOOD, Colo., Dec. 27, 2022 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE:AMPE) (the "Company") today announced that it has received notification from The NYSE American LLC ("NYSE American")